A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB
Clinical trial NCT05484466 · UNKNOWN
Trial details
- NCT number
- NCT05484466
- Sponsor
- Shanghai Zhimeng Biopharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-11
- Primary completion
- 2022-12-20
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.